Market Cap (In INR)
2.13 Billion
Revenue (In INR)
504.21 Million
Net Income (In INR)
-197.28 Million
Avg. Volume
11.3 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 60.0-129.0
- PE
- -
- EPS
- -
- Beta Value
- 0.455
- ISIN
- INE268B01013
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jitendra Rameshchandra Shah
- Employee Count
- -
- Website
- https://krebsbiochem.com
- Ipo Date
- 2004-01-02
- Details
- Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad, India.
More Stocks
-
002688
-
KUMPFINKUMBHAT FINANCIAL SERVICES LTD
KUMPFIN
-
JZCP
-
IMTLImage Protect, Inc.
IMTL
-
HKXCY
-
S68
-
300421
-
MLNOVNovatech Industries
MLNOV